Yun-Wei Chang
Acute Care · Milton, FLNPI 1255708459
Payments from drug & device makers
Across 222 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$920
- AbbVie$422
- GSK$344
- Bayer$298
- Dexcom, Inc.$246
- Otsuka America Pharmaceutical, Inc.$205
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,537100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 59 | $920 |
| AbbVie | 30 | $422 |
| GSK | 26 | $344 |
| Bayer | 18 | $298 |
| Dexcom, Inc. | 10 | $246 |
| Otsuka America Pharmaceutical, Inc. | 15 | $205 |
| AstraZeneca | 8 | $195 |
| Johnson & Johnson | 13 | $189 |
| Lilly USA, LLC | 8 | $130 |
| Pfizer | 5 | $88 |
| Phathom Pharmaceuticals, Inc. | 5 | $66 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $47 |
| Amgen | 3 | $47 |
| Sunovion Pharmaceuticals Inc. | 3 | $42 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Lundbeck LLC | 1 | $29 |
| Shield Therapeutics Inc | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 2 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Biosense Webster, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Merck | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
How this compares
$3,537 in reported general payments places this provider in the 90th percentile of 1,150 acute care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 48 | $56,688 |
| RybelsusSemaglutide | 46 | $54,067 |
| FarxigaDapagliflozin Propanediol | 54 | $46,550 |
| OzempicSemaglutide | 38 | $44,020 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 52 | $43,323 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 58 | $42,401 |
| EliquisApixaban | 41 | $40,561 |
| LinzessLinaclotide | 43 | $34,741 |
| VraylarCariprazine Hcl | 19 | $29,313 |
| JanuviaSitagliptin Phosphate | 26 | $23,322 |
| TrulicityDulaglutide | 23 | $22,099 |
| MyrbetriqMirabegron | 36 | $20,056 |
| VascepaIcosapent Ethyl | 21 | $10,013 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $4,003 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 142 | $3,708 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $920 | $98,08784 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $195 | $88,950112 claims |
| Lilly USA, LLCMounjaro, Trulicity | $130 | $78,78771 claims |
| AbbVieLinzess, Vraylar | $422 | $64,05562 claims |
| GSKTrelegy Ellipta | $344 | $43,32352 claims |
| PfizerEliquis | $88 | $40,56141 claims |
| MerckJanuvia | $12 | $23,32226 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,150 acute care providers in Florida.
Other acute care in Milton
- Tracey TaylorMilton$5K
- Melisa WilsonOrlando$3.6M
- Amanda PeacockJacksonville$81K
- Katrina RileyTampa$66K
- Diane GrayLake Mary$49K
- Heather RamousSafety Harbor$38K
- Melanie WeresJacksonville$37K
- Jayne JaramilloJacksonville$27K
- Melissa HamiltonTampa$23K
- Kimberly GrantAltamonte Springs$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.